Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-07-09

Clinical Trial Update: Efficacy of Nalmefene in Patients With Alcohol Dependence [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluated Nalmefene for alcohol dependence. The study has completed and results were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nalmefene (nalmefene)

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Alcohol Dependence | Phase 3 | Status: COMPLETED | Results posted: 2013-07-09